Labor and Delivery Practice Questions

Q: Cesarean section is mandatory in which of the following presentations?

Brow. **Explanation:** The correct answer is **Brow presentation**. In this presentation, the fetal head is midway between full flexion and full extension. The engaging diameter is the **mentovertical diameter**, which measures approximately **13.5 cm**. Since this diameter exceeds the average dimensions of the maternal pelvic inlet (the largest being the transverse diameter at 13 cm), a persistent brow presentation is physically impossible to deliver vaginally. Therefore, a Cesarean section is mandatory unless the presentation spontaneously converts to a vertex or face presentation. **Analysis of Incorrect Options:** * **A & B (Cephalic/Vertex):** These are the most common and favorable presentations for vaginal delivery. In vertex presentation, the head is well-flexed, presenting the **suboccipitobregmatic diameter (9.5 cm)**, which easily negotiates the birth canal. * **C (Face):** Vaginal delivery is possible in face presentation provided the position is **Mentum Anterior**. In this case, the submentobregmatic diameter (9.5 cm) engages. However, if the position is **Mentum Posterior**, vaginal delivery is impossible, and a Cesarean section is required. Since face presentation *can* be delivered vaginally, it is not "mandatory" for all cases. **High-Yield Clinical Pearls for NEET-PG:** * **Largest Engaging Diameter:** Mentovertical (13.5 cm) – seen in Brow presentation. * **Smallest Engaging Diameter:** Suboccipitobregmatic (9.5 cm) – seen in well-flexed Vertex. * **Mnemonic for Face Presentation:** "Posterior is prohibited" (Mentum posterior cannot deliver vaginally). * **Brow Presentation Management:** If diagnosed early in labor, one may wait for spontaneous conversion. If it persists in active labor, **Cesarean section is the only safe mode of delivery.**

Q: Late decelerations in fetal heart rate monitoring are most commonly caused by which of the following conditions?

Uteroplacental insufficiency. **Explanation:** **1. Why Uteroplacental Insufficiency is Correct:** Late decelerations are characterized by a gradual decrease in fetal heart rate (FHR) where the **nadir (lowest point) occurs after the peak of the uterine contraction**. This delay is the hallmark of **uteroplacental insufficiency**. During a contraction, uterine blood flow decreases; if the placenta is already compromised (due to preeclampsia, IUGR, or post-term pregnancy), the fetus experiences transient hypoxemia. This triggers chemoreceptors, leading to a vagal response and myocardial depression, resulting in the characteristic "late" drop in heart rate. **2. Why Other Options are Incorrect:** * **B. Umbilical Cord Compression:** This causes **Variable Decelerations**, which are abrupt in onset and recovery and often V-shaped. They are not necessarily synchronized with contractions. * **C. Fetal Head Compression:** This causes **Early Decelerations**. The nadir of the FHR coincides with the peak of the contraction ("mirror image"). This is a physiological response due to increased intracranial pressure and is not indicative of fetal distress. * **D. Fetal Anemia:** This typically presents as a **Sinusoidal Pattern** on the FHR tracing, characterized by a smooth, undulating wave-like pattern. **3. High-Yield Clinical Pearls for NEET-PG:** * **Early Deceleration:** Head compression (Benign/Physiological). * **Variable Deceleration:** Cord compression (Most common type seen in labor). * **Late Deceleration:** Uteroplacental insufficiency (Always pathological; indicates fetal hypoxia/acidosis). * **Management of Late Decelerations:** Immediate steps include lateral decubitus positioning, oxygen supplementation, IV fluids, and stopping oxytocin. If persistent, urgent delivery is indicated.

Q: Which of the following are included in the Bishop's score?

All of the above. The **Bishop’s Score** (also known as the Pelvic Score) is a clinical tool used to assess the "ripeness" of the cervix and predict the likelihood of a successful vaginal delivery following the induction of labor. ### **Explanation of the Correct Answer** The Bishop’s score evaluates five distinct parameters, all of which are included in the options provided: 1. **Dilation of the cervix:** Measured in centimeters (0 to >5 cm). 2. **Effacement:** Measured as a percentage or by the length of the cervix remaining (0 to >80%). 3. **Consistency (Softening):** Categorized as firm, medium, or soft. 4. **Position of the cervix:** Categorized as posterior, mid-position, or anterior. 5. **Station of the fetal head:** Measured relative to the ischial spines (-3 to +2). Since dilation, effacement, and softening are three of the five core components, **Option D (All of the above)** is the correct answer. ### **Why Other Options are Incorrect** Options A, B, and C are individual components of the score. Selecting any one of them exclusively would be incomplete, as the Bishop’s score is a composite assessment of all these physical findings combined. ### **High-Yield Clinical Pearls for NEET-PG** * **Maximum Score:** 13. * **Interpretation:** A score of **≥8** suggests a "ripe" cervix with a high probability of successful induction (similar to spontaneous labor). A score of **≤6** suggests an "unripe" cervix, often requiring cervical ripening agents (e.g., Dinoprostone/PGE2). * **Mnemonic (STAT-D):** **S**tation, **T**exture (Consistency), **A**ttitude (Position), **T**hickness (Effacement), **D**ilation. * **Modified Bishop Score:** Often replaces effacement percentage with cervical length (cm) for more objective measurement.

Q: A 25-year-old G1P1 woman with a history of a previous vaginal breech delivery of a term, live baby presents with a full-term pregnancy and breech presentation. What is the best management option?

Assisted breech delivery. **Explanation:** The correct management for this patient is **Assisted Breech Delivery**. The clinical cornerstone here is the patient’s obstetric history: she is a **multigravida with a previous successful vaginal breech delivery** of a term, live baby. This indicates an "adequately tested pelvis" and a proven ability to deliver a breech fetus vaginally. In such cases, if the current pregnancy is also a term breech with no other contraindications (like footling presentation or hyperextension of the head), vaginal delivery is a safe and preferred option. **Why other options are incorrect:** * **Cesarean Section:** While the Term Breech Trial (2000) increased the rates of elective CS for breech, current guidelines (ACOG/RCOG) support vaginal delivery in carefully selected cases, especially in multiparous women with a proven pelvis. * **External Cephalic Version (ECV):** ECV is typically performed between 36–37 weeks to reduce the incidence of breech at term. Since the patient is already at "full-term" and likely in labor or ready for delivery, the window for a safe ECV has passed. * **Watchful Expectancy:** This is inappropriate as breech delivery requires active monitoring and skilled assistance during the second stage of labor to prevent complications like cord prolapse or head entrapment. **High-Yield Clinical Pearls for NEET-PG:** * **Prerequisites for Vaginal Breech:** Average fetal weight (2.5–3.5 kg), Frank or Complete breech presentation, flexed fetal head, and an adequate maternal pelvis. * **Burn-Marshall Maneuver:** Used for delivery of the after-coming head (allowing the baby to hang to use gravity). * **Mauriceau-Smellie-Veit Maneuver:** The most common manual method for delivering the after-coming head. * **Piper Forceps:** The specialized forceps used specifically for the after-coming head in breech.

Q: What is the recommended concentration of MgSO4 in meq/L for the treatment of eclampsia?

4 7 meq/L. **Explanation:** Magnesium Sulfate ($MgSO_4$) is the drug of choice for both the prophylaxis and treatment of seizures in eclampsia. The therapeutic goal is to maintain a specific serum concentration that is high enough to prevent seizures but low enough to avoid systemic toxicity. **1. Why 4–7 mEq/L is correct:** The therapeutic window for $MgSO_4$ in eclampsia is **4–7 mEq/L** (equivalent to 4.8–8.4 mg/dL). At this concentration, magnesium acts as a CNS depressant and a vasodilator, effectively raising the seizure threshold without compromising vital functions. **2. Analysis of Incorrect Options:** * **2–4 mEq/L (Option C):** This is below the therapeutic range. While normal physiological magnesium levels are 1.5–2.5 mEq/L, concentrations in this range are insufficient to prevent eclamptic convulsions. * **7–10 mEq/L (Option A):** This range approaches the threshold of toxicity. Loss of patellar reflexes (knee jerk) typically occurs when levels exceed **7–10 mEq/L** (or >10 mg/dL). * **10–15 mEq/L (Option B):** This is a dangerously toxic range. Respiratory depression and narcosis generally occur at **12–15 mEq/L**, and cardiac arrest is imminent when levels exceed **25–30 mEq/L**. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Always check for the presence of the **Patellar reflex**, Respiratory rate (>12-14/min), and Urine output (>30 ml/hr or 100 ml/4hrs) before administering repeat doses. * **Antidote:** If toxicity occurs, the immediate treatment is **10 ml of 10% Calcium Gluconate** IV, administered slowly over 10 minutes. * **Excretion:** Magnesium is almost exclusively excreted by the kidneys; hence, dose adjustment is mandatory in renal impairment.

Q: Which drug is given to reduce uterine contractions during preterm labor with the least side effects?

Progesterone. **Explanation:** The correct answer is **Progesterone**. In the context of preterm labor management, it is crucial to distinguish between **prevention** and **acute tocolysis**. **Why Progesterone is Correct:** Progesterone is primarily used for the **prevention** of preterm birth in high-risk women (e.g., those with a short cervix or prior history). It maintains "uterine quiescence" by inhibiting pro-inflammatory cytokines and decreasing oxytocin receptors. Among all drugs listed, it has the **least systemic side effect profile**, as it mimics a natural pregnancy hormone. While not used to stop active, advanced labor, it is the drug of choice for long-term reduction of uterine irritability with minimal maternal-fetal risks. **Analysis of Incorrect Options:** * **Ritodrine:** A Beta-2 agonist. It is notorious for severe side effects, including maternal tachycardia, pulmonary edema, and hyperglycemia. It is now rarely used due to these safety concerns. * **Nifedipine:** A Calcium Channel Blocker. While it is the **first-line agent for acute tocolysis** due to better efficacy and fewer side effects than Ritodrine, it can still cause maternal hypotension, flushing, and headaches. * **Magnesium Sulfate:** Primarily used for **fetal neuroprotection** (if <32 weeks) rather than as a primary tocolytic. It carries risks of respiratory depression and loss of deep tendon reflexes at toxic levels. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for Acute Tocolysis:** Nifedipine. * **DOC for Fetal Neuroprotection:** Magnesium Sulfate. * **Progesterone Formulations:** Vaginal progesterone is preferred for "short cervix," while IM 17-OHP is used for a history of prior preterm birth. * **Tocolytic Contraindication:** Do not give tocolytics if there is evidence of chorioamnionitis or abruption.

Q: A positive "Stallworthy's sign" is suggestive of which of the following conditions?

Low lying placenta. **Explanation:** **Stallworthy’s Sign** is a classic clinical sign used to diagnose a **posterior low-lying placenta (Placenta Previa)**. 1. **Why the correct answer is right:** In cases of a posterior low-lying placenta, the bulk of the placenta occupies the space over the sacral promontory. This prevents the fetal head from engaging and pushes it forward. Clinically, this manifests as a **persistently high, non-engaged fetal head** that is displaced anteriorly. When pressure is applied to the fetal head to push it into the pelvic inlet, the fetal heart rate (FHR) slows down due to compression of the placenta/cord against the pelvic rim. When the pressure is released, the FHR returns to normal. This positive finding is Stallworthy’s sign. 2. **Why the incorrect options are wrong:** * **Twin pregnancy:** Presents with a "large for dates" uterus and multiple fetal parts, but does not typically cause positional FHR changes related to head engagement. * **Breech presentation:** While it may result in a non-engaged head in the fundus, it does not involve placental compression at the pelvic brim. * **Vesicular mole:** Characterized by "snowstorm appearance" on USG and high hCG levels; it is a gestational trophoblastic disease, not a placental site anomaly. **High-Yield Clinical Pearls for NEET-PG:** * **Dangerous Placenta:** Posterior placenta previa is often called the "dangerous placenta" because it is more likely to cause cord compression and is harder to detect on routine exams compared to anterior types. * **Management:** The definitive diagnosis for placenta previa is **Transvaginal Ultrasound (TVS)**, which is considered the gold standard and is safe. * **Macafee’s Regimen:** This is the expectant management protocol for placenta previa (aiming for 37 weeks) provided the mother is stable and the fetus is preterm.

Question 1

All of the following are indications for early clamping of the umbilical cord except?

Accepted Answer

Postdated pregnancy

Answer

Preterm delivery

Answer

Bih's asphyxia

Answer

Maternal diabetes

Question 2

Cesarean section is mandatory in which of the following presentations?

Accepted Answer

Brow

Answer

Cephalic

Answer

Vertex

Answer

Face

Question 3

An elderly multiparous woman with intrauterine fetal death was admitted with strong labor pains. The patient suddenly goes into shock with cyanosis, respiratory disturbances, and pulmonary edema. What is the most likely clinical diagnosis?

Accepted Answer

Amniotic fluid embolism

Answer

Rupture of uterus

Answer

Congestive heart failure

Answer

Concealed accidental hemorrhage

Question 4

Which of the following obstetric conditions can be detected using a Partogram?

Accepted Answer

Obstructed labour

Answer

Abruptio placentae

Answer

Incoordinate uterine action

Answer

Postpartum hemorrhage (PPH)

Question 5

Late decelerations in fetal heart rate monitoring are most commonly caused by which of the following conditions?

Accepted Answer

Uteroplacental insufficiency

Answer

Umbilical cord compression

Answer

Fetal head compression

Answer

Fetal anemia due to Rh incompatibility

Question 6

Which of the following are included in the Bishop's score?

Accepted Answer

All of the above

Answer

Dilation of the cervix

Answer

Effacement

Answer

Cervical softening

Question 7

A 25-year-old G1P1 woman with a history of a previous vaginal breech delivery of a term, live baby presents with a full-term pregnancy and breech presentation. What is the best management option?

Accepted Answer

Assisted breech delivery

Answer

Cesarean section

Answer

External cephalic version

Answer

Watchful expectancy

Question 8

What is the recommended concentration of MgSO4 in meq/L for the treatment of eclampsia?

Accepted Answer

4 
 7 meq/L

Answer

7 
 10 meq/L

Answer

10 
 15 meq/L

Answer

2 
 4 meq/L

Question 9

Which drug is given to reduce uterine contractions during preterm labor with the least side effects?

Accepted Answer

Progesterone

Answer

Ritodrine

Answer

Nifedipine

Answer

Magnesium sulfate

Question 10

A positive "Stallworthy's sign" is suggestive of which of the following conditions?

Accepted Answer

Low lying placenta

Answer

Twin pregnancy

Answer

Breech presentation

Answer

Vesicular mole

Labor and Delivery — MCQs

Labor and Delivery — MCQs

On this page

Practice by Chapter

Want unlimited practice?